What is NDC 70121-1642?

70121-1642 is the product NDC for vasopressin, Vasopressin 20 [USP'U]/mL injection, listed with the FDA by Amneal Pharmaceuticals LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.

Amneal Pharmaceuticals LLC, NDC labeler code 70121. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for vasopressin?

19 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

vasopressin NDC 70121-1642 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70121-1642Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70121-1642Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70121-1642-2	70121164202	1 VIAL in 1 CARTON (70121-1642-2) / 1 mL in 1 VIAL (70121-1642-1)Marketed from Aug 11, 2022
70121-1642-5	70121164205	25 VIAL in 1 CARTON (70121-1642-5) / 1 mL in 1 VIAL (70121-1642-1)Marketed from Aug 11, 2022
70121-1642-7	70121164207	10 VIAL in 1 CARTON (70121-1642-7) / 1 mL in 1 VIAL (70121-1642-1)Marketed from Aug 11, 2022

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): vasopressin
Generic name (nonproprietary): vasopressin
Active ingredients: Vasopressin — 20 [USP'U]/mL
Dosage form: Injection
Route: Intravenous
Labeler: Amneal Pharmaceuticals LLCNDC labeler code 70121
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212944
Marketing start: Aug 11, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Diuresis (Physiologic effect)Vasoconstriction (Physiologic effect)Vasopressins (Chemical structure)
Identifiers: Product ID 70121-1642_852dfca1-d3f4-4c85-8140-1b74e464ec0cSPL ID 852dfca1-d3f4-4c85-8140-1b74e464ec0cSPL set ID d9869345-b02c-4225-a97b-656f14c86decRxCUI 2103182UNII Y4907O6MFDUPC 0370121164258, 0370121164210, 0370121164272

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N470121164202 followed by a unit qualifier and the quantity

Package 70121-1642-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 7, 2024.

Indications (excerpt from the label)

Vasopressin injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. Vasopressin injection is indicated to increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70121-1642

What is NDC 70121-1642?: 70121-1642 is the product NDC for vasopressin, Vasopressin 20 [USP'U]/mL injection, listed with the FDA by Amneal Pharmaceuticals LLC. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: vasopressin.
What is the active ingredient?: Vasopressin.
Who is the labeler?: Amneal Pharmaceuticals LLC, NDC labeler code 70121. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for vasopressin?: 19 other product NDCs are listed under this name. See all vasopressin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other vasopressin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Vasopressin	Vasopressin 20 [USP'U]/mL	Injection, SolutionIntravenous	Civica, Inc.	72572-860	72572-0860-25
Vasopressin	Vasopressin .4 [USP'U]/mL	InjectionIntravenous	Gland Pharma Limited	68083-663	68083-0663-10
Vasopressin	Vasopressin 20 [USP'U]/mL	Injection, SolutionIntravenous	Sagent Pharmaceuticals	25021-474	25021-0474-01
vasopressin	Vasopressin, Unspecified 20 [USP'U]/mL	InjectionIntravenous	Dr. Reddy's Laboratories, Inc.	43598-914	43598-0914-06
Vasopressin	Vasopressin, Unspecified 20 [USP'U]/mL	InjectionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1694	51662-1694-02
vasopressin	Vasopressin, Unspecified 20 [USP'U]/mL	InjectionIntravenous	Medical Purchasing Solutions, LLC	71872-7334	71872-7334-01
Vasopressin	Vasopressin 20 [USP'U]/mL	InjectionIntravenous	Gland Pharma Limited	68083-520	68083-0520-1068083-0520-25
Vasopressin	Vasopressin 20 [USP'U]/mL	Injection, SolutionIntravenous	American Regent, Inc.	0517-1030	00517-1030-01
Vasopressin	Vasopressin 20 [USP'U]/mL	Injection, SolutionIntravenous	HF Acquisition Co LLC, DBA HealthFirst	51662-1682	51662-1682-02
Vasopressin	Vasopressin 20 [USP'U]/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	63323-930	63323-0930-01

All 20 vasopressin NDCs